Literature DB >> 23045695

Dendritic cells sequester antigenic epitopes for prolonged periods in the absence of antigen-encoding genetic information.

Changying Li1, Matthew R Buckwalter, Sreyashi Basu, Manish Garg, Jiwu Chang, Pramod K Srivastava.   

Abstract

Studies with a number of viral systems have shown, on the basis of the ability of a host to prime naïve T cells, that viral antigens persist in the infected host well beyond complete clearance of the infection and even when viral antigen is undetectable by the most sensitive methods. This has led to a reasonable assumption that the antigen persists through persistence of antigen-encoding genetic information (DNA or RNA) that resides in the host at a subdetectable level. Here, we demonstrate that epitopes, or epitope precursors, of a model antigen (ovalbumin) persist in a host for prolonged periods (weeks), well beyond the time at which the intact antigen has disappeared, and in the complete absence of genetic information encoding it. Dendritic cells are shown to be the site of this epitope sequestration in vivo, as well as in cultures in vitro. For sequestration to occur, the uptaken antigen must be significantly large, that is, the epitope and its 18-mer precursor are not sequestered. Dendritic cells are shown to create an hsp90-dependent intracellular pool of epitopes or epitope precursors that continues to release epitopes for presentation on the major histocompatibility complex I molecules for prolonged periods. Demonstration of such long-term sequestration of antigenic epitopes inside dendritic cells presents new opportunities for stimulation of immune response against cancers and viruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23045695      PMCID: PMC3491476          DOI: 10.1073/pnas.1205867109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Transient aggregation of ubiquitinated proteins during dendritic cell maturation.

Authors:  Hugues Lelouard; Evelina Gatti; Fanny Cappello; Olivia Gresser; Voahirana Camosseto; Philippe Pierre
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

2.  Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity.

Authors:  Andrea A Itano; Stephen J McSorley; R Lee Reinhardt; Benjamin D Ehst; Elizabeth Ingulli; Alexander Y Rudensky; Marc K Jenkins
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

Review 3.  Antigen presentation to naive CD4 T cells in the lymph node.

Authors:  Andrea A Itano; Marc K Jenkins
Journal:  Nat Immunol       Date:  2003-08       Impact factor: 25.606

4.  The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node.

Authors:  Michael Sixt; Nobuo Kanazawa; Manuel Selg; Thomas Samson; Gunnel Roos; Dieter P Reinhardt; Reinhard Pabst; Manfred B Lutz; Lydia Sorokin
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

5.  Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution.

Authors:  W J Storkus; H J Zeh; R D Salter; M T Lotze
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-08

6.  Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.

Authors:  T Ishii; H Udono; T Yamano; H Ohta; A Uenaka; T Ono; A Hizuta; N Tanaka; P K Srivastava; E Nakayama
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

7.  Latency and persistence of respiratory syncytial virus despite T cell immunity.

Authors:  Jurgen Schwarze; Diarmund R O'Donnell; Angela Rohwedder; Peter J M Openshaw
Journal:  Am J Respir Crit Care Med       Date:  2004-01-23       Impact factor: 21.405

8.  Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue.

Authors:  I Mori; T Komatsu; K Takeuchi; K Nakakuki; M Sudo; Y Kimura
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

9.  Initiation and maintenance of persistent infection by respiratory syncytial virus.

Authors:  C R P'ringle; P V Shirodaria; P Cash; D J Chiswell; P Malloy
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

Review 10.  The clinical applications of heat shock protein inhibitors in cancer - present and future.

Authors:  Udai Banerji; Ian Judson; Paul Workman
Journal:  Curr Cancer Drug Targets       Date:  2003-10       Impact factor: 3.428

View more
  6 in total

Review 1.  Dying cells actively regulate adaptive immune responses.

Authors:  Nader Yatim; Sean Cullen; Matthew L Albert
Journal:  Nat Rev Immunol       Date:  2017-03-13       Impact factor: 53.106

Review 2.  Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.

Authors:  Natasa Strbo; Arlene Garcia-Soto; Taylor H Schreiber; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Identification of the cellular sentinels for native immunogenic heat shock proteins in vivo.

Authors:  Michelle Nicole Messmer; Joshua Pasmowitz; Laura Elizabeth Kropp; Simon C Watkins; Robert Julian Binder
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

4.  Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses.

Authors:  Gabriel Kristian Pedersen; Katharina Wørzner; Peter Andersen; Dennis Christensen
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

Review 5.  Trial watch: Dendritic cell-based interventions for cancer therapy.

Authors:  Erika Vacchelli; Ilio Vitale; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fučíková; Isabelle Cremer; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-07-29       Impact factor: 8.110

6.  CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma.

Authors:  Hakimeh Ebrahimi-Nik; William L Corwin; Tatiana Shcheglova; Alok Das Mohapatra; Ion I Mandoiu; Pramod K Srivastava
Journal:  Cancer Immunol Immunother       Date:  2018-07-20       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.